nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclizine—CYP1A2—type 2 diabetes mellitus	0.601	1	CbGaD
Meclizine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0854	0.329	CbGbCtD
Meclizine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0672	0.259	CbGbCtD
Meclizine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0636	0.245	CbGbCtD
Meclizine—CYP1A2—Losartan—type 2 diabetes mellitus	0.0433	0.167	CbGbCtD
Meclizine—Anaphylactoid reaction—Repaglinide—type 2 diabetes mellitus	0.00358	0.0356	CcSEcCtD
Meclizine—Drowsiness—Glipizide—type 2 diabetes mellitus	0.00221	0.0219	CcSEcCtD
Meclizine—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.0021	0.0209	CcSEcCtD
Meclizine—Drowsiness—Glimepiride—type 2 diabetes mellitus	0.00206	0.0205	CcSEcCtD
Meclizine—Drowsiness—Bromocriptine—type 2 diabetes mellitus	0.00186	0.0185	CcSEcCtD
Meclizine—Fatigue—Tolazamide—type 2 diabetes mellitus	0.00183	0.0182	CcSEcCtD
Meclizine—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.0017	0.0169	CcSEcCtD
Meclizine—Fatigue—Nateglinide—type 2 diabetes mellitus	0.0017	0.0169	CcSEcCtD
Meclizine—Vision blurred—Glipizide—type 2 diabetes mellitus	0.00163	0.0162	CcSEcCtD
Meclizine—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.00161	0.016	CcSEcCtD
Meclizine—Drowsiness—Gliclazide—type 2 diabetes mellitus	0.00153	0.0152	CcSEcCtD
Meclizine—Asthenia—Tolazamide—type 2 diabetes mellitus	0.00152	0.0151	CcSEcCtD
Meclizine—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.00152	0.0151	CcSEcCtD
Meclizine—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.00151	0.015	CcSEcCtD
Meclizine—Headache—Tolbutamide—type 2 diabetes mellitus	0.00146	0.0145	CcSEcCtD
Meclizine—Asthenia—Nateglinide—type 2 diabetes mellitus	0.00141	0.014	CcSEcCtD
Meclizine—Fatigue—Rosiglitazone—type 2 diabetes mellitus	0.00139	0.0138	CcSEcCtD
Meclizine—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.00137	0.0136	CcSEcCtD
Meclizine—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.00135	0.0134	CcSEcCtD
Meclizine—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.00134	0.0133	CcSEcCtD
Meclizine—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.00134	0.0133	CcSEcCtD
Meclizine—Headache—Tolazamide—type 2 diabetes mellitus	0.00133	0.0132	CcSEcCtD
Meclizine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00133	0.0132	CcSEcCtD
Meclizine—Headache—Linagliptin—type 2 diabetes mellitus	0.00132	0.0131	CcSEcCtD
Meclizine—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00131	0.0131	CcSEcCtD
Meclizine—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00131	0.013	CcSEcCtD
Meclizine—Anaphylactoid reaction—Ramipril—type 2 diabetes mellitus	0.0013	0.013	CcSEcCtD
Meclizine—Drowsiness—Metformin—type 2 diabetes mellitus	0.00128	0.0127	CcSEcCtD
Meclizine—Somnolence—Glipizide—type 2 diabetes mellitus	0.00125	0.0124	CcSEcCtD
Meclizine—Vision blurred—Glyburide—type 2 diabetes mellitus	0.00125	0.0124	CcSEcCtD
Meclizine—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.00121	0.012	CcSEcCtD
Meclizine—Somnolence—Glimepiride—type 2 diabetes mellitus	0.00117	0.0116	CcSEcCtD
Meclizine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00116	0.0116	CcSEcCtD
Meclizine—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.00116	0.0116	CcSEcCtD
Meclizine—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.00115	0.0115	CcSEcCtD
Meclizine—Fatigue—Glimepiride—type 2 diabetes mellitus	0.00113	0.0113	CcSEcCtD
Meclizine—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.00113	0.0112	CcSEcCtD
Meclizine—Headache—Repaglinide—type 2 diabetes mellitus	0.00107	0.0106	CcSEcCtD
Meclizine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00105	0.0105	CcSEcCtD
Meclizine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.00103	0.0103	CcSEcCtD
Meclizine—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00102	0.0102	CcSEcCtD
Meclizine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00102	0.0101	CcSEcCtD
Meclizine—Asthenia—Glipizide—type 2 diabetes mellitus	0.00101	0.01	CcSEcCtD
Meclizine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00101	0.01	CcSEcCtD
Meclizine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000993	0.00987	CcSEcCtD
Meclizine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000968	0.00962	CcSEcCtD
Meclizine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000943	0.00937	CcSEcCtD
Meclizine—Vision blurred—Metformin—type 2 diabetes mellitus	0.00094	0.00935	CcSEcCtD
Meclizine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00094	0.00934	CcSEcCtD
Meclizine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000912	0.00907	CcSEcCtD
Meclizine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000901	0.00896	CcSEcCtD
Meclizine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000894	0.00889	CcSEcCtD
Meclizine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000887	0.00882	CcSEcCtD
Meclizine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000883	0.00878	CcSEcCtD
Meclizine—Headache—Glipizide—type 2 diabetes mellitus	0.000882	0.00877	CcSEcCtD
Meclizine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000865	0.0086	CcSEcCtD
Meclizine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000851	0.00846	CcSEcCtD
Meclizine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000845	0.0084	CcSEcCtD
Meclizine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000839	0.00834	CcSEcCtD
Meclizine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000835	0.0083	CcSEcCtD
Meclizine—Headache—Glimepiride—type 2 diabetes mellitus	0.000823	0.00818	CcSEcCtD
Meclizine—Flunarizine—CALM1—type 2 diabetes mellitus	0.000821	0.147	CrCbGaD
Meclizine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000821	0.00816	CcSEcCtD
Meclizine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000795	0.0079	CcSEcCtD
Meclizine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000784	0.00779	CcSEcCtD
Meclizine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000778	0.00773	CcSEcCtD
Meclizine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000771	0.00766	CcSEcCtD
Meclizine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000768	0.00764	CcSEcCtD
Meclizine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000762	0.00757	CcSEcCtD
Meclizine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000743	0.00738	CcSEcCtD
Meclizine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000738	0.00733	CcSEcCtD
Meclizine—Somnolence—Metformin—type 2 diabetes mellitus	0.000724	0.0072	CcSEcCtD
Meclizine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000723	0.00719	CcSEcCtD
Meclizine—Fatigue—Metformin—type 2 diabetes mellitus	0.000702	0.00698	CcSEcCtD
Meclizine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000698	0.00694	CcSEcCtD
Meclizine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000683	0.00679	CcSEcCtD
Meclizine—Headache—Glyburide—type 2 diabetes mellitus	0.000679	0.00675	CcSEcCtD
Meclizine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000662	0.00659	CcSEcCtD
Meclizine—Somnolence—Losartan—type 2 diabetes mellitus	0.000643	0.00639	CcSEcCtD
Meclizine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000641	0.00638	CcSEcCtD
Meclizine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000634	0.0063	CcSEcCtD
Meclizine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000633	0.00629	CcSEcCtD
Meclizine—Loperamide—CALM1—type 2 diabetes mellitus	0.000632	0.113	CrCbGaD
Meclizine—Fatigue—Losartan—type 2 diabetes mellitus	0.000623	0.0062	CcSEcCtD
Meclizine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00062	0.00616	CcSEcCtD
Meclizine—Headache—Gliclazide—type 2 diabetes mellitus	0.00061	0.00606	CcSEcCtD
Meclizine—Asthenia—Metformin—type 2 diabetes mellitus	0.000584	0.00581	CcSEcCtD
Meclizine—Headache—Valsartan—type 2 diabetes mellitus	0.00056	0.00557	CcSEcCtD
Meclizine—Headache—Orlistat—type 2 diabetes mellitus	0.000553	0.0055	CcSEcCtD
Meclizine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000551	0.00548	CcSEcCtD
Meclizine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000551	0.00548	CcSEcCtD
Meclizine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000535	0.00531	CcSEcCtD
Meclizine—Asthenia—Losartan—type 2 diabetes mellitus	0.000519	0.00516	CcSEcCtD
Meclizine—Headache—Metformin—type 2 diabetes mellitus	0.00051	0.00507	CcSEcCtD
Meclizine—Headache—Irbesartan—type 2 diabetes mellitus	0.000481	0.00479	CcSEcCtD
Meclizine—Fluspirilene—ADRA2A—type 2 diabetes mellitus	0.000459	0.0821	CrCbGaD
Meclizine—Headache—Losartan—type 2 diabetes mellitus	0.000453	0.0045	CcSEcCtD
Meclizine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000445	0.00442	CcSEcCtD
Meclizine—Headache—Ramipril—type 2 diabetes mellitus	0.000388	0.00386	CcSEcCtD
Meclizine—Nefazodone—ADRA2A—type 2 diabetes mellitus	0.000341	0.061	CrCbGaD
Meclizine—Bifonazole—CYP2E1—type 2 diabetes mellitus	0.000338	0.0605	CrCbGaD
Meclizine—Nefazodone—HTR2C—type 2 diabetes mellitus	0.000314	0.0562	CrCbGaD
Meclizine—Azelastine—CYP2E1—type 2 diabetes mellitus	0.000278	0.0497	CrCbGaD
Meclizine—Imatinib—CYP1A2—type 2 diabetes mellitus	0.000272	0.0488	CrCbGaD
Meclizine—Azelastine—CYP1A2—type 2 diabetes mellitus	0.000264	0.0473	CrCbGaD
Meclizine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	0.00026	0.0466	CrCbGaD
Meclizine—Flunarizine—CYP1A2—type 2 diabetes mellitus	0.000258	0.0462	CrCbGaD
Meclizine—Bifonazole—CYP3A4—type 2 diabetes mellitus	0.000213	0.0381	CrCbGaD
Meclizine—Cinnarizine—CYP1A2—type 2 diabetes mellitus	0.000204	0.0366	CrCbGaD
Meclizine—Imatinib—CYP3A4—type 2 diabetes mellitus	0.00018	0.0323	CrCbGaD
Meclizine—Azelastine—CYP3A4—type 2 diabetes mellitus	0.000175	0.0313	CrCbGaD
Meclizine—Imatinib—ALB—type 2 diabetes mellitus	0.000157	0.0282	CrCbGaD
Meclizine—Nefazodone—CYP3A4—type 2 diabetes mellitus	0.000157	0.0281	CrCbGaD
Meclizine—Loperamide—CYP3A4—type 2 diabetes mellitus	0.000132	0.0236	CrCbGaD
Meclizine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	0.00013	0.0233	CrCbGaD
Meclizine—HRH1—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	4.38e-05	0.00129	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	4.36e-05	0.00128	CbGpPWpGaD
Meclizine—CYP1A2—Biological oxidations—GSTM1—type 2 diabetes mellitus	4.35e-05	0.00128	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—AVP—type 2 diabetes mellitus	4.33e-05	0.00128	CbGpPWpGaD
Meclizine—CYP1A2—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	4.29e-05	0.00127	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	4.26e-05	0.00126	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	4.23e-05	0.00125	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	4.16e-05	0.00123	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—EDN1—type 2 diabetes mellitus	4.12e-05	0.00122	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	4.09e-05	0.00121	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	4.04e-05	0.00119	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	3.98e-05	0.00117	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	3.87e-05	0.00114	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	3.77e-05	0.00111	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GCGR—type 2 diabetes mellitus	3.76e-05	0.00111	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	3.71e-05	0.0011	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	3.7e-05	0.00109	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	3.69e-05	0.00109	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	3.68e-05	0.00109	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—C3—type 2 diabetes mellitus	3.6e-05	0.00106	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	3.59e-05	0.00106	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	3.57e-05	0.00105	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GIPR—type 2 diabetes mellitus	3.46e-05	0.00102	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GRK5—type 2 diabetes mellitus	3.46e-05	0.00102	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	3.42e-05	0.00101	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—AGT—type 2 diabetes mellitus	3.42e-05	0.00101	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	3.38e-05	0.000997	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	3.38e-05	0.000997	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	3.34e-05	0.000986	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	3.32e-05	0.00098	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—BHMT—type 2 diabetes mellitus	3.32e-05	0.000978	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	3.26e-05	0.000963	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	3.25e-05	0.000958	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	3.23e-05	0.000954	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MC4R—type 2 diabetes mellitus	3.16e-05	0.000934	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	3.16e-05	0.000933	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	3.15e-05	0.000929	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	3.11e-05	0.000918	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	3.11e-05	0.000917	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GIP—type 2 diabetes mellitus	3.05e-05	0.000899	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	3.02e-05	0.00089	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	2.94e-05	0.000866	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—AANAT—type 2 diabetes mellitus	2.9e-05	0.000855	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PTGDS—type 2 diabetes mellitus	2.9e-05	0.000855	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—LEPR—type 2 diabetes mellitus	2.89e-05	0.000854	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	2.89e-05	0.000852	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	2.88e-05	0.00085	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	2.87e-05	0.000847	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	2.86e-05	0.000844	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	2.83e-05	0.000836	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	2.83e-05	0.000834	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	2.82e-05	0.000832	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	2.77e-05	0.000816	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	2.76e-05	0.000813	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CDO1—type 2 diabetes mellitus	2.75e-05	0.000811	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GPD2—type 2 diabetes mellitus	2.75e-05	0.000811	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TLE4—type 2 diabetes mellitus	2.69e-05	0.000794	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	2.69e-05	0.000792	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	2.67e-05	0.000788	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—AK1—type 2 diabetes mellitus	2.62e-05	0.000773	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—GCG—type 2 diabetes mellitus	2.62e-05	0.000772	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	2.59e-05	0.000765	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	2.59e-05	0.000764	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	2.57e-05	0.000759	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	2.5e-05	0.000738	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	2.48e-05	0.000733	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	2.45e-05	0.000723	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SLC5A4—type 2 diabetes mellitus	2.42e-05	0.000714	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—MAT1A—type 2 diabetes mellitus	2.42e-05	0.000714	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	2.41e-05	0.000711	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	2.36e-05	0.000698	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	2.34e-05	0.000691	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.34e-05	0.000689	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ND1—type 2 diabetes mellitus	2.34e-05	0.000689	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—G6PC—type 2 diabetes mellitus	2.34e-05	0.000689	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ENPP1—type 2 diabetes mellitus	2.34e-05	0.000689	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HBA2—type 2 diabetes mellitus	2.34e-05	0.000689	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	2.33e-05	0.000687	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	2.31e-05	0.000681	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	2.29e-05	0.000675	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	2.29e-05	0.000675	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	2.26e-05	0.000668	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	2.25e-05	0.000665	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	2.23e-05	0.000658	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—RBP4—type 2 diabetes mellitus	2.23e-05	0.000658	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—AVP—type 2 diabetes mellitus	2.22e-05	0.000656	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	2.22e-05	0.000656	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	2.22e-05	0.000655	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	2.21e-05	0.000653	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	2.19e-05	0.000647	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	2.14e-05	0.000631	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	2.14e-05	0.000631	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	2.12e-05	0.000624	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	2.08e-05	0.000614	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	2.08e-05	0.000614	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—C3—type 2 diabetes mellitus	2.04e-05	0.000601	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	2.01e-05	0.000593	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.99e-05	0.000586	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	1.99e-05	0.000586	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	1.99e-05	0.000586	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	1.99e-05	0.000586	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.97e-05	0.000583	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—INSR—type 2 diabetes mellitus	1.96e-05	0.000579	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.93e-05	0.000571	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.93e-05	0.000569	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.93e-05	0.000568	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.92e-05	0.000566	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	1.9e-05	0.000562	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	1.9e-05	0.000562	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.89e-05	0.000558	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—C3—type 2 diabetes mellitus	1.85e-05	0.000545	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.84e-05	0.000542	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.83e-05	0.000541	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	1.83e-05	0.000541	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	1.8e-05	0.000531	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.8e-05	0.000531	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.79e-05	0.000527	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.78e-05	0.000526	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.78e-05	0.000526	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.77e-05	0.000522	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	1.77e-05	0.000522	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	1.77e-05	0.000522	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.76e-05	0.000518	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.73e-05	0.000512	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.73e-05	0.000509	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.73e-05	0.000509	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.72e-05	0.000506	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.7e-05	0.000501	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.69e-05	0.000499	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.69e-05	0.000499	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.67e-05	0.000492	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	1.66e-05	0.000491	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.64e-05	0.000484	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.62e-05	0.000479	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.6e-05	0.000472	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.57e-05	0.000464	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.56e-05	0.000462	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	1.56e-05	0.00046	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.56e-05	0.000459	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.55e-05	0.000456	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.55e-05	0.000456	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.52e-05	0.000449	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.52e-05	0.000447	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	1.51e-05	0.000444	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	1.51e-05	0.000444	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	1.51e-05	0.000444	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	1.51e-05	0.000444	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.45e-05	0.000427	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.45e-05	0.000427	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	1.44e-05	0.000426	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.42e-05	0.000419	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.42e-05	0.000419	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.4e-05	0.000414	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.37e-05	0.000405	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.36e-05	0.000401	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.34e-05	0.000397	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	1.34e-05	0.000396	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.33e-05	0.000393	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.31e-05	0.000388	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.31e-05	0.000388	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.31e-05	0.000386	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.3e-05	0.000384	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.29e-05	0.00038	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.27e-05	0.000375	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.26e-05	0.000373	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	1.25e-05	0.00037	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.25e-05	0.000369	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	1.23e-05	0.000362	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	1.23e-05	0.000362	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.21e-05	0.000358	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	1.2e-05	0.000355	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.2e-05	0.000353	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	1.2e-05	0.000353	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	1.2e-05	0.000353	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	1.2e-05	0.000353	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.19e-05	0.000351	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.19e-05	0.00035	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.17e-05	0.000344	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	1.15e-05	0.00034	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.14e-05	0.000336	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.12e-05	0.00033	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	1.09e-05	0.000322	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.08e-05	0.000317	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	1.07e-05	0.000317	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	1.07e-05	0.000317	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	1.07e-05	0.000317	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	1.05e-05	0.000311	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	1.04e-05	0.000308	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.04e-05	0.000307	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.04e-05	0.000306	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.04e-05	0.000306	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.03e-05	0.000304	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.02e-05	0.000301	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.02e-05	0.000301	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.02e-05	0.0003	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.02e-05	0.0003	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1e-05	0.000296	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	9.81e-06	0.00029	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	9.7e-06	0.000286	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.59e-06	0.000283	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	9.46e-06	0.000279	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.41e-06	0.000278	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	9.3e-06	0.000274	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	9.3e-06	0.000274	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.07e-06	0.000268	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	8.68e-06	0.000256	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.54e-06	0.000252	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.4e-06	0.000248	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.39e-06	0.000248	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.36e-06	0.000247	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	8.02e-06	0.000237	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.02e-06	0.000237	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	7.98e-06	0.000235	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.98e-06	0.000235	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	7.87e-06	0.000232	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	7.64e-06	0.000226	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.61e-06	0.000225	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.61e-06	0.000225	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	7.44e-06	0.000219	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	7.3e-06	0.000215	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	7.17e-06	0.000211	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	7.15e-06	0.000211	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	7.12e-06	0.00021	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	6.94e-06	0.000205	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	6.85e-06	0.000202	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	6.57e-06	0.000194	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.53e-06	0.000193	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.47e-06	0.000191	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	6.45e-06	0.00019	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.42e-06	0.00019	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	6.24e-06	0.000184	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	6.14e-06	0.000181	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	6.12e-06	0.000181	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.11e-06	0.00018	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	6.05e-06	0.000178	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.04e-06	0.000178	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.93e-06	0.000175	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.63e-06	0.000166	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.49e-06	0.000162	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	5.33e-06	0.000157	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	5.23e-06	0.000154	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.04e-06	0.000149	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.94e-06	0.000146	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	4.79e-06	0.000141	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.58e-06	0.000135	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	4.58e-06	0.000135	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	4.19e-06	0.000124	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.79e-06	0.000112	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.5e-06	0.000103	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	2.11e-06	6.22e-05	CbGpPWpGaD
